Buscar
-
Safety of antituberculosis agents used for multidrug-resistant tuberculosis among patients attending the Jamot Hospital of Yaounde, Cameroon
(International Journal of Mycobacteriology. vol. 12, n° 2, pp. 168-174, 2023-06-15)Article de revueLibre acceso -
Development and validation of a case-finding algorithm for the identification of non-small cell lung cancers in a region-wide Italian pathology registry
(PLoS ONE. vol. 17, n° 6, 2022-06-08)Article de revueLibre acceso -
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
(Therapies, 2023-03-07)Article de revue -
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer
(Targeted Oncology. vol. 18, n° 5, pp. 717-726, 2023-09-01)Article de revue -
Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
(Therapies, 2023-03-11)Article de revue -
Dual Orexin Receptor Antagonists and Suicide Risk: Findings From the WHO Spontaneous Reporting Database
(Journal of Clinical Psychiatry. vol. 84, n° 6, 2023-09-27)Article de revue -
Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
(Therapies. vol. 78, n° 1, pp. 115-129, 2022-11-25)Article de revue -
Neuromodulation Treatments of Pathological Anxiety in Anxiety Disorders, Stressor-Related Disorders, and Major Depressive Disorder: A Dimensional Systematic Review and Meta-Analysis
(Frontiers in Psychiatry. vol. 13, 2022-07-01)Article de revueLibre acceso -
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis
(Drug Safety, 2024-03-18)Article de revue -
The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science
(Frontiers in Neurology. vol. 12, pp. 631722, 2021-03-11)Article de revueLibre acceso